BBPWM
LAB icon

Blue Bell Private Wealth Management’s Standard BioTools LAB Stock Holding History

Blue Bell Private Wealth Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-200
Closed -$1K – 852
2022
Q1 		$1K Buy
+200
New +$691 ﹤0.01% 803

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blue Bell Private Wealth Management's LAB Position: Q2 2022 in Review

Blue Bell Private Wealth Management sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 200 shares — an estimated $1K sold.

Blue Bell Private Wealth Management first reported a position in LAB in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

  • Blue Bell Private Wealth Management reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 200 Standard BioTools shares in Q2 2022, an estimated $1K.
  • Blue Bell Private Wealth Management first reported a position in Standard BioTools in Q1 2022 and held it in 1 quarter.
  • Blue Bell Private Wealth Management's Standard BioTools position peaked at $1K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2022, filed 2 Aug 2022.